Massage for Prostate Cancer-Related Fatigue, mPROSTATE Study

Inclusion Criteria:

Male subjects aged >= 45 years old
Histologically confirmed diagnosis of prostate cancer
Subjects must have completed radiation therapy >= 2 months, prior to registration
Subjects undergoing androgen depravation therapy with serum testosterone levels < 20 ng/ml
Subjects who have a score > 25 on the Brief Fatigue Inventory (BFI) at screening
Subjects who are fluent in speaking and reading English

Based on International Classification of Diseases (ICD)-10 proposed criteria, the patient must have a diagnosis of CRF with evidence from the history, physical exam, and laboratory findings that the fatigue is a consequence of cancer or cancer therapy and not primarily a consequence of any of the following:

Comorbid psychiatric disorders
Anemia (hemoglobin less than 10 g/dl)
Hypothyroidism (thyroid stimulating hormone (TSH) greater than 4.6 micro-international units (uIU)/mL)
Uncontrolled pain

Any medical or psychiatric condition or medication felt to be clinically contributing to fatigue based on the investigator's history, physical examination, and assessment. These medical circumstances may include:

The use of medications such as opioids, sedating anti-histamines, or neuroleptics;
Medical problems associated with fatigue: chronic obstructive pulmonary disease, congestive heart failure, renal disease, hepatic dysfunction, uncontrolled autoimmune disease, neurological disorders such as multiple sclerosis or Parkinson's disease, and sleep apnea
Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines

Exclusion Criteria:

Inability to lay supine for one hour at a time, given the nature of the massage intervention
Body-mass index less than 18.5 (kg/m^2)
Treatment with corticosteroids or other immunosuppressants =< 6 months prior to registration, , unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement..
Subjects who cannot comply with the protocol for any reason
Regular use of anti-inflammatory drugs including non-steroidal anti-inflammatory drugs and natural products thought to have anti-inflammatory properties, unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement..
Change in prescribed dose of medications for anxiety or depression =< 4 weeks prior to registration.
Change in fluoxetine dose within =< 8 weeks prior to registration
Subjects meeting criteria for a current substance use diagnosis or current diagnoses of schizophrenia, depression, generalized anxiety disorder, bipolar disorder, dementia, delirium, or obsessive compulsive disorder (OCD)
Subjects who are actively suicidal or homicidal

Other conditions or behaviors that, in the opinion of the treating investigator, may negatively impact study participation, including the following:

Illicit drug use
Shift work
Current dieting
Excessive regular use of alcohol (more than two 5-ounce glasses of wine or equivalents/day)
Any instance of binge drinking (more than 7 drinks in a 24-hour period) =< 6 months prior to registration
Current and/or past use of massage for the treatment of fatigue.
Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information, give informed consent, comply with the study protocol, or complete the study